Hormone Therapy Insights

JoAnn highlights the differences between FDA-approved bioidentical hormone therapies and those from compounding pharmacies, emphasizing the potential risks associated with the latter. She cautions against the misconception that compounded hormones are inherently safer, noting that they lack regulatory oversight and may not deliver the promised benefits. Additionally, the reliance on hormone level testing for monitoring is questioned, as symptom response should be the primary focus.